Findings show safety of BNT162b2 or CoronaVac vaccines in patients with cardiovascular disease
Moderna Says Omicron-Specific Booster Should Be Ready by August
Vaccine targets both omicron and the original strain of the virus
Primary Care Outreach Boosts COVID-19 Vaccination Rates
Electronic and mail messages from primary care providers increased COVID-19 vaccination rates among Black and Latino older adults
With CDC Approval, COVID-19 Shots for Under 5s Ready for Delivery
Health officials have said the federal government will be ready to ship doses out this week
FDA Approves Pfizer, Moderna Shots for Those 5 Years and Younger
U.S. Centers for Disease Control and Prevention will vote on Saturday on whether to endorse the shots
Protection Against Omicron Strongest With Hybrid Immunity
Immunity resulting from previous COVID-19 infection and recent booster vaccination confers strongest protection against omicron infection
FDA Panel Backs Pfizer, Moderna Shots for Children 5 Years and Younger
Panel’s recommendations will now go to the FDA, which is expected to approve use of the vaccines this week
Veterans Report Low Rates of Adverse Events With mRNA Vaccines
Rates slightly higher at 42 days for those receiving Pfizer versus Moderna
COVID-19 Vaccines Cut Mortality With Heart Failure
Those who are partially vaccinated and unvaccinated face same increased risk, while boosted and fully vaccinated adults fare best
FDA Advisors Back Moderna Shot for Older Children, Teens
Some panel members noted that the vaccine would likely help prevent serious illness but not be as good at blocking mild infections